Europe Cancer Biomarkers Market Report 2016
- QYR729113
- 124 Pages
- October 2016
- Medical Devices
Sales, means the sales volume of Cancer Biomarkers
Revenue, means the sales value of Cancer Biomarkers
This report studies sales (consumption) of Cancer Biomarkers in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Abbott Laboratories (U.S.)
Affymetrix Inc. (U.S.)
Roche Diagnostics Ltd. (Switzerland)
Illumina, Inc. (U.S.)
Qiagen NV (Netherlands)
Agilent Technologies (U.S.)
Thermo Fisher Scientific Inc. (U.S.)
Merck & Co. Inc. (U.S.)
Becton Dickinson and Company (U.S.)
Hologic Inc. (U.S.)
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Cancer Biomarkers in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Protein Biomarkers
Genetic Biomarkers
Others
Split by application, this report focuses on sales, market share and growth rate of Cancer Biomarkers in each application, can be divided into
Diagnostics
Drug Discovery and Development
Prognostics
Risk Assessment
Others?
Europe Cancer Biomarkers Market Report 2016
1 Cancer Biomarkers Overview
1.1 Product Overview and Scope of Cancer Biomarkers
1.2 Classification of Cancer Biomarkers
1.2.1 Protein Biomarkers
1.2.2 Genetic Biomarkers
1.2.3 Others
1.3 Application of Cancer Biomarkers
1.3.1 Diagnostics
1.3.2 Drug Discovery and Development
1.3.3 Prognostics
1.3.4 Risk Assessment
1.3.5 Others?
1.4 Cancer Biomarkers Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Cancer Biomarkers (2011-2021)
1.5.1 Europe Cancer Biomarkers Sales and Growth Rate (2011-2021)
1.5.2 Europe Cancer Biomarkers Revenue and Growth Rate (2011-2021)
2 Europe Cancer Biomarkers by Manufacturers, Type and Application
2.1 Europe Cancer Biomarkers Market Competition by Manufacturers
2.1.1 Europe Cancer Biomarkers Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Cancer Biomarkers Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Cancer Biomarkers (Volume and Value) by Type
2.2.1 Europe Cancer Biomarkers Sales and Market Share by Type (2011-2016)
2.2.2 Europe Cancer Biomarkers Revenue and Market Share by Type (2011-2016)
2.3 Europe Cancer Biomarkers (Volume and Value) by Countries
2.3.1 Europe Cancer Biomarkers Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Cancer Biomarkers Revenue and Market Share by Countries (2011-2016)
2.4 Europe Cancer Biomarkers (Volume) by Application
3 Germany Cancer Biomarkers (Volume, Value and Sales Price)
3.1 Germany Cancer Biomarkers Sales and Value (2011-2016)
3.1.1 Germany Cancer Biomarkers Sales and Growth Rate (2011-2016)
3.1.2 Germany Cancer Biomarkers Revenue and Growth Rate (2011-2016)
3.1.3 Germany Cancer Biomarkers Sales Price Trend (2011-2016)
3.2 Germany Cancer Biomarkers Sales and Market Share by Manufacturers
3.3 Germany Cancer Biomarkers Sales and Market Share by Type
3.4 Germany Cancer Biomarkers Sales and Market Share by Application
4 France Cancer Biomarkers (Volume, Value and Sales Price)
4.1 France Cancer Biomarkers Sales and Value (2011-2016)
4.1.1 France Cancer Biomarkers Sales and Growth Rate (2011-2016)
4.1.2 France Cancer Biomarkers Revenue and Growth Rate (2011-2016)
4.1.4 France Cancer Biomarkers Sales Price Trend (2011-2016)
4.2 France Cancer Biomarkers Sales and Market Share by Manufacturers
4.3 France Cancer Biomarkers Sales and Market Share by Type
4.4 France Cancer Biomarkers Sales and Market Share by Application
5 UK Cancer Biomarkers (Volume, Value and Sales Price)
5.1 UK Cancer Biomarkers Sales and Value (2011-2016)
5.1.1 UK Cancer Biomarkers Sales and Growth Rate (2011-2016)
5.1.2 UK Cancer Biomarkers Revenue and Growth Rate (2011-2016)
5.1.5 UK Cancer Biomarkers Sales Price Trend (2011-2016)
5.2 UK Cancer Biomarkers Sales and Market Share by Manufacturers
5.3 UK Cancer Biomarkers Sales and Market Share by Type
5.4 UK Cancer Biomarkers Sales and Market Share by Application
6 Russia Cancer Biomarkers (Volume, Value and Sales Price)
6.1 Russia Cancer Biomarkers Sales and Value (2011-2016)
6.1.1 Russia Cancer Biomarkers Sales and Growth Rate (2011-2016)
6.1.2 Russia Cancer Biomarkers Revenue and Growth Rate (2011-2016)
6.1.6 Russia Cancer Biomarkers Sales Price Trend (2011-2016)
6.2 Russia Cancer Biomarkers Sales and Market Share by Manufacturers
6.3 Russia Cancer Biomarkers Sales and Market Share by Type
6.4 Russia Cancer Biomarkers Sales and Market Share by Application
7 Italy Cancer Biomarkers (Volume, Value and Sales Price)
7.1 Italy Cancer Biomarkers Sales and Value (2011-2016)
7.1.1 Italy Cancer Biomarkers Sales and Growth Rate (2011-2016)
7.1.2 Italy Cancer Biomarkers Revenue and Growth Rate (2011-2016)
7.1.7 Italy Cancer Biomarkers Sales Price Trend (2011-2016)
7.2 Italy Cancer Biomarkers Sales and Market Share by Manufacturers
7.3 Italy Cancer Biomarkers Sales and Market Share by Type
7.4 Italy Cancer Biomarkers Sales and Market Share by Application
8 Spain Cancer Biomarkers (Volume, Value and Sales Price)
8.1 Spain Cancer Biomarkers Sales and Value (2011-2016)
8.1.1 Spain Cancer Biomarkers Sales and Growth Rate (2011-2016)
8.1.2 Spain Cancer Biomarkers Revenue and Growth Rate (2011-2016)
8.1.8 Spain Cancer Biomarkers Sales Price Trend (2011-2016)
8.2 Spain Cancer Biomarkers Sales and Market Share by Manufacturers
8.3 Spain Cancer Biomarkers Sales and Market Share by Type
8.4 Spain Cancer Biomarkers Sales and Market Share by Application
9 Benelux Cancer Biomarkers (Volume, Value and Sales Price)
9.1 Benelux Cancer Biomarkers Sales and Value (2011-2016)
9.1.1 Benelux Cancer Biomarkers Sales and Growth Rate (2011-2016)
9.1.2 Benelux Cancer Biomarkers Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Cancer Biomarkers Sales Price Trend (2011-2016)
9.2 Benelux Cancer Biomarkers Sales and Market Share by Manufacturers
9.3 Benelux Cancer Biomarkers Sales and Market Share by Type
9.4 Benelux Cancer Biomarkers Sales and Market Share by Application
10 Europe Cancer Biomarkers Manufacturers Analysis
10.1 Abbott Laboratories (U.S.)
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Cancer Biomarkers Product Type, Application and Specification
10.1.2.1 Type I
10.1.2.2 Type II
10.1.3 Abbott Laboratories (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 Affymetrix Inc. (U.S.)
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Cancer Biomarkers Product Type, Application and Specification
10.2.2.1 Type I
10.2.2.2 Type II
10.2.3 Affymetrix Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main Business/Business Overview
10.3 Roche Diagnostics Ltd. (Switzerland)
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Cancer Biomarkers Product Type, Application and Specification
10.3.2.1 Type I
10.3.2.2 Type II
10.3.3 Roche Diagnostics Ltd. (Switzerland) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 Illumina, Inc. (U.S.)
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Cancer Biomarkers Product Type, Application and Specification
10.4.2.1 Type I
10.4.2.2 Type II
10.4.3 Illumina, Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main Business/Business Overview
10.5 Qiagen NV (Netherlands)
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Cancer Biomarkers Product Type, Application and Specification
10.5.2.1 Type I
10.5.2.2 Type II
10.5.3 Qiagen NV (Netherlands) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main Business/Business Overview
10.6 Agilent Technologies (U.S.)
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Cancer Biomarkers Product Type, Application and Specification
10.6.2.1 Type I
10.6.2.2 Type II
10.6.3 Agilent Technologies (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.6.4 Main Business/Business Overview
10.7 Thermo Fisher Scientific Inc. (U.S.)
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Cancer Biomarkers Product Type, Application and Specification
10.7.2.1 Type I
10.7.2.2 Type II
10.7.3 Thermo Fisher Scientific Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.7.4 Main Business/Business Overview
10.8 Merck & Co. Inc. (U.S.)
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Cancer Biomarkers Product Type, Application and Specification
10.8.2.1 Type I
10.8.2.2 Type II
10.8.3 Merck & Co. Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.8.4 Main Business/Business Overview
10.9 Becton Dickinson and Company (U.S.)
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Cancer Biomarkers Product Type, Application and Specification
10.9.2.1 Type I
10.9.2.2 Type II
10.9.3 Becton Dickinson and Company (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main Business/Business Overview
10.10 Hologic Inc. (U.S.)
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Cancer Biomarkers Product Type, Application and Specification
10.10.2.1 Type I
10.10.2.2 Type II
10.10.3 Hologic Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.10.4 Main Business/Business Overview
11 Cancer Biomarkers Manufacturing Cost Analysis
11.1 Cancer Biomarkers Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Cancer Biomarkers
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Cancer Biomarkers Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Cancer Biomarkers Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Cancer Biomarkers Market Forecast (2016-2021)
14.1 Germany Cancer Biomarkers Sales Forecast (2016-2021)
14.2 France Cancer Biomarkers Sales Forecast (2016-2021)
14.3 UK Cancer Biomarkers Sales Forecast (2016-2021)
14.4 Russia Cancer Biomarkers Sales Forecast (2016-2021)
14.5 Italy Cancer Biomarkers Sales Forecast (2016-2021)
14.6 Spain Cancer Biomarkers Sales Forecast (2016-2021)
14.7 Benelux Cancer Biomarkers Sales Forecast (2016-2021)
14.8 Europe Cancer Biomarkers Sales Forecast by Type (2016-2021)
14.9 Europe Cancer Biomarkers Sales Forecast by Application (2016-2021)
15 Research Findings and Conclusion
16 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
Figure Picture of Cancer Biomarkers
Table Classification of Cancer Biomarkers
Figure Europe Sales Market Share of Cancer Biomarkers by Type in 2015
Figure Protein Biomarkers Picture
Figure Genetic Biomarkers Picture
Figure Others Picture
Table Application of Cancer Biomarkers
Figure Europe Sales Market Share of Cancer Biomarkers by Application in 2015
Figure Diagnostics Examples
Figure Drug Discovery and Development Examples
Figure Prognostics Examples
Figure Risk Assessment Examples
Figure Others? Examples
Figure Germany Cancer Biomarkers Revenue and Growth Rate (2011-2021)
Figure France Cancer Biomarkers Revenue and Growth Rate (2011-2021)
Figure UK Cancer Biomarkers Revenue and Growth Rate (2011-2021)
Figure Russia Cancer Biomarkers Revenue and Growth Rate (2011-2021)
Figure Italy Cancer Biomarkers Revenue and Growth Rate (2011-2021)
Figure Spain Cancer Biomarkers Revenue and Growth Rate (2011-2021)
Figure Benelux Cancer Biomarkers Revenue and Growth Rate (2011-2021)
Figure Europe Cancer Biomarkers Sales and Growth Rate (2011-2021)
Figure Europe Cancer Biomarkers Revenue and Growth Rate (2011-2021)
Table Europe Cancer Biomarkers Sales of Key Manufacturers (2015 and 2016)
Table Europe Cancer Biomarkers Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Biomarkers Sales Share by Manufacturers
Figure 2016 Cancer Biomarkers Sales Share by Manufacturers
Table Europe Cancer Biomarkers Revenue by Manufacturers (2015 and 2016)
Table Europe Cancer Biomarkers Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Cancer Biomarkers Revenue Share by Manufacturers
Table 2016 Europe Cancer Biomarkers Revenue Share by Manufacturers
Table Europe Cancer Biomarkers Sales and Market Share by Type (2011-2016)
Table Europe Cancer Biomarkers Sales Share by Type (2011-2016)
Figure Sales Market Share of Cancer Biomarkers by Type (2011-2016)
Figure Europe Cancer Biomarkers Sales Growth Rate by Type (2011-2016)
Table Europe Cancer Biomarkers Revenue and Market Share by Type (2011-2016)
Table Europe Cancer Biomarkers Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Cancer Biomarkers by Type (2011-2016)
Figure Europe Cancer Biomarkers Revenue Growth Rate by Type (2011-2016)
Table Europe Cancer Biomarkers Sales and Market Share by Countries (2011-2016)
Table Europe Cancer Biomarkers Sales Share by Countries (2011-2016)
Figure Sales Market Share of Cancer Biomarkers by Countries (2011-2016)
Table Europe Cancer Biomarkers Revenue and Market Share by Countries (2011-2016)
Table Europe Cancer Biomarkers Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Cancer Biomarkers by Countries (2011-2016)
Table Europe Cancer Biomarkers Sales and Market Share by Application (2011-2016)
Table Europe Cancer Biomarkers Sales Share by Application (2011-2016)
Figure Sales Market Share of Cancer Biomarkers by Application (2011-2016)
Figure Germany Cancer Biomarkers Sales and Growth Rate (2011-2016)
Figure Germany Cancer Biomarkers Revenue and Growth Rate (2011-2016)
Figure Germany Cancer Biomarkers Sales Price Trend (2011-2016)
Table Germany Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table Germany Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table Germany Cancer Biomarkers Sales by Type (2015 and 2016)
Table Germany Cancer Biomarkers Market Share by Type (2015 and 2016)
Table Germany Cancer Biomarkers Sales by Application (2015 and 2016)
Table Germany Cancer Biomarkers Market Share by Application (2015 and 2016)
Figure France Cancer Biomarkers Sales and Growth Rate (2011-2016)
Figure France Cancer Biomarkers Revenue and Growth Rate (2011-2016)
Figure France Cancer Biomarkers Sales Price Trend (2011-2016)
Table France Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table France Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table France Cancer Biomarkers Sales by Type (2015 and 2016)
Table France Cancer Biomarkers Market Share by Type (2015 and 2016)
Table France Cancer Biomarkers Sales by Application (2015 and 2016)
Table France Cancer Biomarkers Market Share by Application (2015 and 2016)
Figure UK Cancer Biomarkers Sales and Growth Rate (2011-2016)
Figure UK Cancer Biomarkers Revenue and Growth Rate (2011-2016)
Figure UK Cancer Biomarkers Sales Price Trend (2011-2016)
Table UK Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table UK Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table UK Cancer Biomarkers Sales by Type (2015 and 2016)
Table UK Cancer Biomarkers Market Share by Type (2015 and 2016)
Table UK Cancer Biomarkers Sales by Application (2015 and 2016)
Table UK Cancer Biomarkers Market Share by Application (2015 and 2016)
Figure Russia Cancer Biomarkers Sales and Growth Rate (2011-2016)
Figure Russia Cancer Biomarkers Revenue and Growth Rate (2011-2016)
Figure Russia Cancer Biomarkers Sales Price Trend (2011-2016)
Table Russia Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table Russia Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table Russia Cancer Biomarkers Sales by Type (2015 and 2016)
Table Russia Cancer Biomarkers Market Share by Type (2015 and 2016)
Table Russia Cancer Biomarkers Sales by Application (2015 and 2016)
Table Russia Cancer Biomarkers Market Share by Application (2015 and 2016)
Figure Italy Cancer Biomarkers Sales and Growth Rate (2011-2016)
Figure Italy Cancer Biomarkers Revenue and Growth Rate (2011-2016)
Figure Italy Cancer Biomarkers Sales Price Trend (2011-2016)
Table Italy Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table Italy Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table Italy Cancer Biomarkers Sales by Type (2015 and 2016)
Table Italy Cancer Biomarkers Market Share by Type (2015 and 2016)
Table Italy Cancer Biomarkers Sales by Application (2015 and 2016)
Table Italy Cancer Biomarkers Market Share by Application (2015 and 2016)
Figure Spain Cancer Biomarkers Sales and Growth Rate (2011-2016)
Figure Spain Cancer Biomarkers Revenue and Growth Rate (2011-2016)
Figure Spain Cancer Biomarkers Sales Price Trend (2011-2016)
Table Spain Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table Spain Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table Spain Cancer Biomarkers Sales by Type (2015 and 2016)
Table Spain Cancer Biomarkers Market Share by Type (2015 and 2016)
Table Spain Cancer Biomarkers Sales by Application (2015 and 2016)
Table Spain Cancer Biomarkers Market Share by Application (2015 and 2016)
Figure Benelux Cancer Biomarkers Sales and Growth Rate (2011-2016)
Figure Benelux Cancer Biomarkers Revenue and Growth Rate (2011-2016)
Figure Benelux Cancer Biomarkers Sales Price Trend (2011-2016)
Table Benelux Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table Benelux Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table Benelux Cancer Biomarkers Sales by Type (2015 and 2016)
Table Benelux Cancer Biomarkers Market Share by Type (2015 and 2016)
Table Benelux Cancer Biomarkers Sales by Application (2015 and 2016)
Table Benelux Cancer Biomarkers Market Share by Application (2015 and 2016)
Table Cancer Biomarkers Basic Information List
Table Abbott Laboratories (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Affymetrix Inc. (U.S.) Basic Information List
Table Affymetrix Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Affymetrix Inc. (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Roche Diagnostics Ltd. (Switzerland) Basic Information List
Table Roche Diagnostics Ltd. (Switzerland) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Diagnostics Ltd. (Switzerland) Cancer Biomarkers Sales Market Share (2011-2016)
Table Illumina, Inc. (U.S.) Basic Information List
Table Illumina, Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Illumina, Inc. (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Qiagen NV (Netherlands) Basic Information List
Table Qiagen NV (Netherlands) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Qiagen NV (Netherlands) Cancer Biomarkers Sales Market Share (2011-2016)
Table Agilent Technologies (U.S.) Basic Information List
Table Agilent Technologies (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Agilent Technologies (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Thermo Fisher Scientific Inc. (U.S.) Basic Information List
Table Thermo Fisher Scientific Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Thermo Fisher Scientific Inc. (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Merck & Co. Inc. (U.S.) Basic Information List
Table Merck & Co. Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co. Inc. (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Becton Dickinson and Company (U.S.) Basic Information List
Table Becton Dickinson and Company (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Becton Dickinson and Company (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Hologic Inc. (U.S.) Basic Information List
Table Hologic Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hologic Inc. (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Biomarkers
Figure Manufacturing Process Analysis of Cancer Biomarkers
Figure Cancer Biomarkers Industrial Chain Analysis
Table Raw Materials Sources of Cancer Biomarkers Major Manufacturers in 2015
Table Major Buyers of Cancer Biomarkers
Table Distributors/Traders List
Figure Germany Cancer Biomarkers Sales and Growth Rate Forecast (2016-2021)
Figure Germany Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)
Figure France Cancer Biomarkers Sales and Growth Rate Forecast (2016-2021)
Figure France Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)
Figure UK Cancer Biomarkers Sales and Growth Rate Forecast (2016-2021)
Figure UK Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Cancer Biomarkers Sales and Growth Rate Forecast (2016-2021)
Figure Russia Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Cancer Biomarkers Sales and Growth Rate Forecast (2016-2021)
Figure Italy Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Cancer Biomarkers Sales and Growth Rate Forecast (2016-2021)
Figure Spain Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Cancer Biomarkers Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)
Table Europe Cancer Biomarkers Sales Forecast by Type (2016-2021)
Table Europe Cancer Biomarkers Sales Forecast by Application (2016-2021)
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
